List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 5 studies with search of: Open Studies | spectrum pharmaceuticals
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Condition: Peripheral T-Cell Lymphoma
Intervention: Drug: PXD101
2 Recruiting A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma
Condition: Carcinoma
Intervention: Drug: SPI-1620
3 Recruiting Study of PXD101 and Doxorubicin to Treat Soft Tissue Sarcomas
Condition: Soft Tissue Sarcomas
Intervention: Drug: PXD101 + doxorubicin
4 Recruiting Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary
Condition: Occult Primary
Interventions: Drug: belinostat, carboplatin, paclitaxel;   Drug: carboplatin, paclitaxel
5 Recruiting Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Solid Tumor;   Lymphoma
Intervention: Drug: belinostat

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services